BLACKROCK Municipal Income TRUST V.BFK.P

Primary Symbol: BFK

BlackRock Municipal Income Trust (the Fund) is a diversified closed-end management investment company. The Fund's investment objective is to provide current income exempt from federal income taxes. Under normal market conditions, the Fund invests at least 80% of its managed assets in investments the income from which is exempt from federal income tax (except that the interest may be subject to the alternative minimum tax). The Fund may invest directly in securities or synthetically through the use of derivatives. The Fund's investment policies provide that it invests at least 80% of its total assets in investment grade quality municipal obligations issued by or on behalf of states, territories and possessions of the United States and their political subdivisions, agencies or instrumentalities, each of which pays interest that, in the opinion of bond counsel to the issuer, is excludable from gross income for federal income tax purposes. Its investment adviser is BlackRock Advisors, LLC.

NYSE:BFK - Post by User

BLACKROCK Municipal Income TRUST > Adj. EBITDA Gap = $11.5 Million

<< Previous

Bullboard Posts

Next >>

Comment by quinlashon Jan 23, 2022 2:35pm

195 Views

Post# 34350198

RE:Adj. EBITDA Gap = $11.5 Million

Last QTR the net revenue number was $50 Million with 29% Q over Q growth. Redecan numbers were not fully accounted for so we have some additional sales coming in from there.

If we speculate on a repeat of last QTR with another 29% Q over Q incremental in sales we have...

$ 50 Million x .29 = $14.5 Million

14.5 Million compared to the 11.5 Million Adj EBITDA gap = HEXO Meeting Debenture Requirements.

DYODD

Q

- Long on HEXO (patiently)

Link to Previous QTR Report Summary
https://www.globenewswire.com/news-release/2021/12/14/2351553/0/en/HEXO-Reports-First-Quarter-2022-Results-and-Launches-New-Strategic-Plan-The-Path-Forward-to-Solidify-its-Position-as-Canada-s-Leading-Cannabis-Company.html

quinlash wrote: HEXO Corp needs to close out a gap of 11.5 Million on the upcoming report and they have yet to report on the full incremental benefit that additional Redecan Sales will bring to the company.

If you care to try and run your own numbers on QTR over QTR growth, incremental sales likely to appear from Redecan, incremental sales potential from 3 international supply agreements, incremental sales from sales in 17 US States... etc etc etc...

You will likely see that 11.5 Million... isn't that much of target to the company to hit. The measure used is Adj EBITDA as well so love it or hate it... it too makes things easier for the company to achieve the needed targets.

DYODD

Q